Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:assetsUnderManagement |
over €2.3 billion
|
| gptkbp:country |
gptkb:Netherlands
|
| gptkbp:focusesOn |
gptkb:biotechnology
life sciences |
| gptkbp:foundedIn |
2000
|
| gptkbp:headquartersLocation |
gptkb:Naarden
|
| https://www.w3.org/2000/01/rdf-schema#label |
Forbion
|
| gptkbp:investedIn |
early-stage companies
late-stage companies |
| gptkbp:managingPartner |
Geert-Jan Mulder
Marco Boorsma Sander Slootweg |
| gptkbp:notableInvestment |
gptkb:Galapagos_NV
gptkb:Replimune NorthSea Therapeutics uniQure |
| gptkbp:officeLocation |
gptkb:Amsterdam
gptkb:Munich gptkb:Singapore |
| gptkbp:website |
https://www.forbion.com/
|
| gptkbp:bfsParent |
gptkb:Ambys_Medicines
|
| gptkbp:bfsLayer |
7
|